Co-Hosted by


Paws for a Cure Research Symposium

Advancing research in pediatric cancer treatments has unique challenges, and progress toward better medicines and a cure has been limited. Intriguingly, BOTH children and our canine companions spontaneously develop a number of cancers with remarkable similarities, including osteosarcoma, certain brain/CNS cancers, lymphoma and leukemia. Speakers, panelists and participants will discuss challenges and progress in accelerating cancer drug development using comparative approaches, including:

  • The state of the art in comparative and novel translational cancer research.
  • Ongoing preclinical, translational and clinical projects leveraging the canine patient model.
  • The most promising prospects for future scientific exploration, collaboration and funding.
  • Life journey presentations by childhood cancer survivors and advocates.

In addition to cutting edge scientific content, the Symposium agenda will include poignant presentations from patient advocates and feature prominent keynote speakers.

If you have questions about this event, contact:

If your company would like to financially support the 2018 Paws for a Cure Research Symposium, please contact:

Who should attend: Pediatric oncologists, veterinary oncologists, translational research scientists in academia and in industry; pharma and biotech professionals in preclinical research, drug development, oncology and animal health; nonprofit and other funders interested in learning about comparative and translational approaches to accelerate development of new and better medicines for the treatment of cancer, particularly devastating shared childhood and canine cancers.

Title Sponsors

In Partnership with

Contributing Sponsor